Insider Buying Activity Uncovered - 7 Stocks On The Rise

This is a must read. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [The New Epicenter for Lithium!]( company makes big acquisition in new epicenter of Lithium supply for EV's! [Get Symbol]( --------------------------------------------------------------- December 13, 2023 Editorial Insights Insider trading occurs when company executives or major shareholders trade stocks based on non-public information. Monitoring these trades provides insight into insiders' expectations for the company's future. For instance, significant purchases before public announcements may indicate anticipated positive news and a potential share price increase. Note: "Insider Buying" is legal stock purchasing by company directors or officers, distinct from illegal insider trading based on non-public information. It's not a crime when based on public information. Insiders, having unique insights, often buy shares when they believe the stock is undervalued. This report lists stocks recently identified with substantial insider buying. --------------------------------------------------------------- Sponsor Message [New EV Lithium Player?]( company surges over 178% after recent acquisition in new Lithium epicenter! [See Report]( --------------------------------------------------------------- [EyePoint Pharmaceuticals]( Ticker: [EYPT]( Recent Price: $19 Average Analyst Price Target: $41.00 (100.00%) Market Cap: $705.13M Role Transaction Description No. of Shares Amount Date >10% Owner Informative Buy Non Open Market Buy 526,315 $9,999,995 2 Days Ago >10% Owner Informative Buy Non Open Market Buy 1,919,057 $41,874,151 8 Days Ago Recent Analyst Action: Zegbeh Jallah, analyst at Capital One Financial, reiterates coverage on [EyePoint Pharmaceuticals (EYPT)]( in the Healthcare sector with a Buy rating and a price target of $44 (2 days ago). Here are 3rd party ratings for [EYPT](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 24% (60 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [This New Tech Could Be Worth THREE TIMES the Entire New York Stock Exchange...]( believe this new tech will create more wealth than all the fortunes of the last 150 years combined. That’s why the world’s richest men and even the United States Senate approved throwing hundreds of BILLIONS of dollars into this new technology… [And right now, there’s a little-known stock at the center of all the action.]( In fact, this small-cap stock is still trading for less than it costs to buy a tank of gas. [Click here now for the whole story.]( --------------------------------------------------------------- [BRC]( Ticker: [BRCC]( Recent Price: $4.13 Average Analyst Price Target: $5.75 (39.23%) Market Cap: $898.73M Role Transaction Description No. of Shares Amount Date Director, >10% Owner Informative Buy Non Open Market Buy 186,440 $770,000 2 Days Ago Recent Analyst Action: Bill Chappell, analyst at Truist Financial, reiterates coverage on [BRC (BRCC)]( in the Real Estate sector with a Hold rating and a price target of $5 (3 weeks ago). Here are 3rd party ratings for [BRCC](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Bottom 32% (170 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Hamilton Insurance Group, Ltd. Class B]( Ticker: [HG]( Recent Price: $15.29 Average Analyst Price Target: $19.40 (27.53%) Market Cap: ― Role Transaction Description No. of Shares Amount Date Director Informative Buy Buy 10,077 $154,078 2 Days Ago Recent Analyst Action: Michael Zaremski, analyst at BMO Capital, reiterates coverage on [Hamilton Insurance Group, Ltd. Class B (HG)]( in the Financial sector with a Buy rating and a price target of $18 (6 days ago). Here are 3rd party ratings for [HG](: - TipRanks.com: Strong Buy - TradingView.com: Neutral - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: n/a - Zacks.com: Hold, Top 11% (27 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [AI "wealth window" will close January 9, 2024?]( Next-generation AI technology will create the first $100 TRILLION industry. AI 2.0 will open a brief “wealth window”… That will slam shut January 9, 2024. [>>HERE is everything you need now<<]( --------------------------------------------------------------- [Catalyst Pharma]( Ticker: [CPRX]( Recent Price: $13.35 Average Analyst Price Target: $23.30 (89.14%) Market Cap: $1.47B Role Transaction Description No. of Shares Amount Date VP, Treasurer and CFO Informative Buy Non Open Market Buy 8,464 $113,000 2 Days Ago Recent Analyst Action: Joon Lee, analyst at Truist Financial, reiterates coverage on [Catalyst Pharma (CPRX)]( in the Healthcare sector with a Buy rating and a price target of $25 (1 month ago). Here are 3rd party ratings for [CPRX](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 25% (62 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Flywire]( Ticker: [FLYW]( Recent Price: $21.90 Average Analyst Price Target: $34.00 (54.34%) Market Cap: $2.66B Role Transaction Description No. of Shares Amount Date President & COO Informative Buy Buy 4,561 $99,898 2 Days Ago Recent Analyst Action: Andrew Harte, analyst at BTIG, reiterates coverage on [Flywire (FLYW)]( in the Technology sector with a Buy rating and a price target of $33 (6 days ago). Here are 3rd party ratings for [FLYW](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Bottom 46% (135 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [My Gift to You]( I have arranged for you to receive [a complimentary 3-month subscription]( to Bernie Schaeffer’s Option Advisor online newsletter. [CLICK HERE]( for 3 Months FREE of Bernie Schaeffer’s Option Advisor ($395 Retail Value - [FREE!]() --------------------------------------------------------------- [Westrock Coffee]( Ticker: [WEST]( Recent Price: $9.76 Average Analyst Price Target: $12.33 (12.70%) Market Cap: $853.10M Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 9,825 $95,900 2 Days Ago Recent Analyst Action: Matthew Smith,, analyst at Stifel Nicolaus, reiterates coverage on [Westrock Coffee (WEST)]( in the Consumer Defensive sector with a Buy rating and a price target of $11 (1 month ago). Here are 3rd party ratings for [WEST](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Sell, Top 7% (17 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Olema Pharmaceuticals]( Ticker: [OLMA]( Recent Price: $12.45 Average Analyst Price Target: $24.80 (103.45%) Market Cap: $626.57M Role Transaction Description No. of Shares Amount Date CH. OPERATING & FINANCIAL Off Informative Buy Buy 5,638 $70,200 2 Days Ago Recent Analyst Action: Sam Slutsky, analyst at LifeSci Capital, reiterates coverage on [Olema Pharmaceuticals (OLMA)]( in the Healthcare sector with a Buy rating and a price target of $26 (1 week ago). Here are 3rd party ratings for [OLMA](: - TipRanks.com: Strong Buy - TradingView.com: Neutral - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 24% (60 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Tiny Lithium Stock Surge!]( t miss out on this tiny stock poised to surge in a massive $183B market opportunity! [Get the Free Report]( --------------------------------------------------------------- And there you have it. To Your Financial Freedom, The Editor InsideTraderAlerts Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. [If you are not a human, click here.]( InsideTraderAlerts part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software